Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Smith

Showing results (381-390 of 406) with videos related to

Pageof 41
Sort By:
Cancer Research|March 31, 2001
Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonistC C Kumar, M Malkowski, Z Yin, et al.
Epilepsy Research|January 7, 2004
Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trialEttore Beghi, Giuliana Gatti, Clara Tonini, et al.
Advances in Experimental Medicine and Biology|August 19, 2000
Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesisC C Kumar, L Armstrong, Z Yin, et al.
The British Journal of Nutrition|March 12, 2021
Systematic review of the effects of pandemic confinements on body weight and their determinantsMoien Ab Khan, Preetha Menon, Romona Govender, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
IL-4 receptor alpha blockade dampens allergic inflammation and upregulates IL-17A expression to promote Saureus clearance in antigen sensitized mouse skinJuan-Manuel Leyva-Castillo, Alex McGurk, Maria Strakosha, et al.
The Journal of Clinical Investigation|May 1, 1990
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-IIIM L Baeza, S R Reddigari, D Kornfeld, et al.
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Supplement|January 1, 1980
Rationale for deployment of short-term assays for evidence of carcinogenicityJ W Drake, F J de Serres, W J Darby, et al.
Critical Reviews in Immunology|January 1, 1996
Opioid and opiate immunoregulatory processesG B Stefano, B Scharrer, E M Smith, et al.
Epilepsia|April 16, 2015
Epilepsy and deprivation, a data linkage studyWilliam O Pickrell, Arron S Lacey, Owen G Bodger, et al.
Journal of Medicinal Chemistry|April 1, 1988
Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolinesE M Smith, G F Swiss, B R Neustadt, et al.
Pageof 41

Showing results (381-390 of 406) with videos related to

Sort By:
Pageof 41
Cancer Research|March 31, 2001
Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonistC C Kumar, M Malkowski, Z Yin, et al.
Epilepsy Research|January 7, 2004
Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trialEttore Beghi, Giuliana Gatti, Clara Tonini, et al.
Advances in Experimental Medicine and Biology|August 19, 2000
Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesisC C Kumar, L Armstrong, Z Yin, et al.
The British Journal of Nutrition|March 12, 2021
Systematic review of the effects of pandemic confinements on body weight and their determinantsMoien Ab Khan, Preetha Menon, Romona Govender, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
IL-4 receptor alpha blockade dampens allergic inflammation and upregulates IL-17A expression to promote Saureus clearance in antigen sensitized mouse skinJuan-Manuel Leyva-Castillo, Alex McGurk, Maria Strakosha, et al.
The Journal of Clinical Investigation|May 1, 1990
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-IIIM L Baeza, S R Reddigari, D Kornfeld, et al.
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Supplement|January 1, 1980
Rationale for deployment of short-term assays for evidence of carcinogenicityJ W Drake, F J de Serres, W J Darby, et al.
Critical Reviews in Immunology|January 1, 1996
Opioid and opiate immunoregulatory processesG B Stefano, B Scharrer, E M Smith, et al.
Epilepsia|April 16, 2015
Epilepsy and deprivation, a data linkage studyWilliam O Pickrell, Arron S Lacey, Owen G Bodger, et al.
Journal of Medicinal Chemistry|April 1, 1988
Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolinesE M Smith, G F Swiss, B R Neustadt, et al.
Pageof 41